Skip to main content

Events

You are here

STARBIOS2: Technology Transfer in the Context of Responsible Research and Innovation

When
Monday, February 18
11:30 a.m. - 3:35 p.m.

Where
UM School of Medicine
HSF II Auditorium, 20 Penn St.

RSVP
Maria Salvato, PhD
Professor, University of Maryland School of Medicine Institute of Human Virology
410-706-1368
msalvato@ihv.umaryland.edu

UM Ventures and STARBIOS2, one of six European Union-funded consortia that studies and promotes Responsible Research and Innovation (RRI), will be hosting a workshop on successful University technology transfer. Hear from individuals who have succeeded in transferring University discoveries and innovations to the public. Discuss technology transfer at University of Maryland, Baltimore. 

Co-sponsored by Jim Hughes and Maria Salvato

Agenda

  • 11:30 a.m. - 12:30 p.m. - Informal scientific meeting on MiRNA, IHV, 6th Floor
  • 12:30 - 1 p.m. - Transition to HSF II Leadership Hall Auditorium, 20 Penn St.
  • 1 p.m. - Bag lunches available just outside of auditorium
  • 1 - 3:35 p.m. - Speakers


Speakers
1 p.m.
Vittorio Colizzi, MD, PhD
Director, University of Rome “Tor Vergata”
“An overview of RRI and the STARBIOS project”

1:15 p.m.
Claire M. Fraser, PhD
Director, University of Maryland School of Medicine (UMSOM) Institute for Genome Science
Dean’s Endowed Professor, UMSOM Department of Medicine
President-Elect, American Association for the Advancement of Science (AAAS)
“Role of the American Association for the Advancement of Science  in promoting Responsible Research and Innovation”

1:30 p.m.
Andrea Declich, PhD
Social scientist and an architect of STARBIOS, University of Rome “Tor Vergata”
“Guidelines for responsible research and innovation”

1:40 p.m.
James B. Kaper, PhD
Professor and Chair, UMSOM Department of Microbiology and Immunology
Senior Associate Dean for Academic Affairs, UMSOM
Co-inventor of cholera vaccine
"The Cholera Vaccine: a UMB invention and its tech transfer process"

1:55 p.m.
Phil Robilotto, DO, MBA
Associate Vice President, University of Maryland, Baltimore (UMB) Office of Technology Transfer
"Technology transfer on the UMB campus promotes RRI"

2:10 p.m.
Meriem Gaval-Cruz, PhD 
Research and Alliances Officer, UMB Office of Technology Transfer
Navigator, UMB Institute for Clinical and Translational Research (ICTR) Training and Career Development Core
"ICTR efforts to incentivize Tech Transfer"

2:20 p.m.
Rana Quraishi, PhD
Director of New Ventures, UMB Office of Research and Development
"Post-graduate education in Entrepreneurship on the UMB campus"

2:35 p.m.
Maria Salvato, PhD
Professor, UMSOM Institute of Human Virology
“Public Engagement as an important aspect of Technology Transfer and an essential  aspect of Responsible Research”

2:40 p.m.
Panel on Integrating Community Engagement at UMB

  • Lori A. Edwards, DrPH, RN, MPH
    Assistant Professor, University of Maryland School of Nursing, Family and Community Health
  • Karen D. Matthews, MPA
    Director, Strategic Planning and Assessment, UMB Office of Institutional Effectiveness, Strategic Planning, and Assessment
  • Ashley Valis, MSW
    Executive Director, UMB Office of Community Engagement
  • Robin Saunders, EdD, MS
    Executive Director, UMB CURE (Continuing Umbrella of Research Experience) Scholars Program

3:20 p.m.
Jim Hughes, MBA
Chief Enterprise and Economic Development Officer and Vice President, UMB
Director, UM Ventures
"Commentary on the UMB efforts to connect with our public through business development" 

ABOUT STARBIOS2
The European Union (EU) Commission has funded an ambitious program to influence the relationship between scientists and society. Large segments of society do not believe that human beings can influence climate change, or that vaccines are beneficial, or that saving a life sometimes needs the tools of modern medicine. Scientists have failed to make their work credible, accessible, and understandable to their non-scientific neighbors. To change this situation, the EU Commission is promoting Responsible Research and Innovation (RRI) that provides five key elements to society: public engagement, open access, ethics, gender equity, and education.

STARBIOS2 (Structural Transformation to Attain Responsible BIOSciences) is one of the six EU-funded consortia that studies and promotes RRI. The consortium includes 12 institutions, all of which have devised action plans to:

  • Engage society more broadly in research and innovation activities.
  • Increase access to scientific results.
  • Ensure gender equity in both the research process and research content.
  • Promote ethical procedures in the practice of research and medicine.
  • Promote formal and informal science education.

The 12 members of STARBIOS2 include nine European institutions (from Italy, the UK, Bulgaria, Poland, Slovenia, Denmark, Sweden, and Germany) and three external institutions (from the USA, South Africa, and Brazil).